Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Natco Pharma Ltd.

Clinical trials sponsored by Natco Pharma Ltd., explained in plain language.

Trials to join now! 1

New hope for head and neck cancer patients who failed immunotherapy

Disease control Recruiting now

This study tests whether adding a new oral drug called NRC-2694-A to standard chemotherapy (paclitaxel) can help control advanced head and neck cancer that has worsened after immunotherapy. About 46 patients who have already tried and progressed on drugs like pembrolizumab or niv…

Phase: PHASE2 • Sponsor: NATCO Pharma Ltd. • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC